Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
-
* Corresponding author: Michael S Hershfield msh@biochem.duke.edu
Arthritis Research & Therapy 2006, 8:R12 doi:10.1186/ar1861
Accesses
- Last 30 days: 70 accesses
- Last year: 990 accesses
- All time: 8756 accesses
Cited by
BioMed Central: 1 citation
|
Developments in the scientific and clinical understanding of gout Alexander So Arthritis Research & Therapy 2008, 10:221 (10 October 2008) This article is part of a collection on The Scientific Basis of... |